|
653 Proposed
CD management plans worry the Society Concern has been expressed
by the Royal Pharmaceutical Society that proposals to improve the management
of Controlled Drugs could jeopardise patient
care
...more
653 Keep
new ethics code simple, says the CCA Simplicity should be
central to the planned revision by the Royal Pharmaceutical Society of
its Code of Ethics, the Company Chemists Association has
said
...more
653 Patient identity
warning Hospital inpatients should wear identification wristbands
at all times and the information shown must be correct, the National
Patient Safety
Agency has warned
...more
653 Independent
prescribing could be beneficial for patients, says BMJ With
appropriate training, support and governance in place, extended prescribing
rights could combine the benefits of high quality pharmaceutical
care with greater convenience and improved access to treatment for
patients
...more
654 Supplies dry
up as flu vaccination rates increase This winter 300,000 more
patients than originally expected have been vaccinated against influenza
in Scotland and only contingency vaccine
stocks remain
...more
654 Safety data
on Tamiflu requested by EMEA A cumulative safety review of
all available data on serious psychiatric disorders involving Roche’s
antiviral drug oseltamivir (Tamiflu) has been requested by the European
Medicines Agency (EMEA) ...more
654 Vaccine handling
fee relaxed In Scotland, the rules for payment of the risk
minimisation fee for handling influenza vaccines were relaxed
...more
654 List of accredited
ETP system suppliers published by CfH The technical accreditation
status of pharmacy systems developed to operate the electronic prescription
service in England have been published
...more
654 Salmeterol/formoterol
reminder from MHRA Prescribers have been reminded that patients
treated with salmeterol (Serevent) or formoterol (Oxis, Foradil) should
always be prescribed
an inhaled corticosteroid
...more
654 NICE recommends
SSRIs for obsessive-compulsive disorder Selective serotonin
reuptake inhibitors have been recommended as treatment for moderate obsessive-compulsive
disorder (OCD) and for patients with
milder OCD who decline or do not respond to psychological treatments
...more
|
655 Manchester
pharmacists sign up for monitoring pilot Community pharmacists
in Greater Manchester are to offer patient monitoring for diabetes and
dyslipidaemia as part of a national pilot funded by the Department of
Health ...more
655 Scottish stoma
appliance supply service Pharmacists in Scotland have until
20 December to decide if they want to provide stoma appliances as part
of a new service ...more
655 Contract-based
business development wins award Developing their pharmacy
business around the new pharmacy contract and engagement with patients
and the local primary care trust has led to Lila and Deepak Thakerar
being named as overall winners of the UniChem Great Business Awards for
2005 ...more
655 Pain and critical
care awards presented at UKCPA meeting Roger Knaggs, from
Queen’s Medical Centre University Hospitals NHS Trust, Nottingham,
received the 2005 Napp pain award at the United Kingdom Clinical Pharmacy
Association symposium in Leeds ...more
655 Anticoagulation
clinic award A pharmacy-based anticoagulation clinic has won
an improvement, creativity and innovation award ...more
656 Greater HIV
prevention needed to slow epidemic HIV infection rates are
decreasing in some countries but the number of people living with HIV
worldwide continues to rise ...more
656 Primary resistance
to anti-HIV drugs increasing in the UK Patients in the UK
have one of the highest rates of primary (transmitted) resistance to
anti-HIV drugs in the world, a BMJ study has revealed ...more
656 Mismatch revealed
between doctors’ and patients’ attitudes to self-injected
therapy Research into attitudes of doctors and patients towards
self-administered injectable therapy suggests doctors are influenced
more by misplaced perceptions of patient antipathy than by published
guidelines ...more
657 Two-pronged
attack of benefit in CV risk reduction Clinicians have exhausted
the lipid-lowering potential of statins and should now turn to combination
therapies in an effort to reduce cardiovascular (CV) risk still further
...more
657 Meta-analysis
indicates celecoxib has CV risk similar to other NSAIDs A
meta-analysis on the cardiovascular safety of the cyclo-oxygenase-2 (COX-2)
inhibitor celecoxib (Celebrex) has found no significant increase in risk
against placebo or other non-steroidal anti-inflammatory drugs (NSAIDs)
...more
657 Homoeopathy
trial suggests benefit: more research needed Positive outcomes
have been reported from a study of patients treated with homoeopathic
remedies for a range of chronic conditions. However, a professor of complementary
medicine says the study's design may limit its conclusions ...more
657 Glucosamine/chondroitin:
no clear benefit in knee pain Glucosamine and chondroitin
supplements show no clear benefit in osteoarthritis knee pain, according
to preliminary data from a US government-funded trial ...more
|
The
Pharmaceutical Journal